Émilie Routier

Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab

Nathalie Chaput, Patricia Lepage, Clélia Coutzac et al. · Annals of Oncology · 2017 · 1.2K citations

Inflammation, Dysbiosis, Mucosal Immunology +14

Association of Vitiligo With Tumor Response in Patients With Metastatic Melanoma Treated With Pembrolizumab

Camille Hua, Lise Boussemart, Christine Mateus et al. · JAMA Dermatology · 2015 · 638 citations

eIF4F is a nexus of resistance to anti-BRAF and anti-MEK cancer therapies

Lise Boussemart, Hélène Malka-Mahieu, Isabelle Girault et al. · Nature · 2014 · 352 citations

Oncology, Anti-mek Cancer Therapies, Medicine +9

Experience in daily practice with ipilimumab for the treatment of patients with metastatic melanoma: an early increase in lymphocyte and eosinophil counts is associated with improved survival

Julie Delyon, Céu Mateus, D. Lefeuvre et al. · Annals of Oncology · 2013 · 306 citations · Full text

Improved Survival, Medicine, Melanoma +9

Safety and efficacy of anti-programmed death 1 antibodies in patients with cancer and pre-existing autoimmune or inflammatory disease

François‐Xavier Danlos, Anne-Laure Voisin, Valérie Dyevre et al. · European Journal of Cancer · 2018 · 304 citations

Anti-programmed Death 1, Inflammatory Disease, Autoimmune Disease +13